204
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Spectroscopic Studies and Antimicrobial Evaluation of New Mixed Ligand Mn(II), Ni(II), Cu(II) Complexes Synthesized from an Ionic Liquid-Supported Schiff Base and 1-Methyl Imidazole

ORCID Icon, , ORCID Icon &
Pages 5962-5974 | Received 04 May 2021, Accepted 28 Jul 2021, Published online: 17 Aug 2021
 

Abstract

Mn(II), Ni(II), Cu(II) complexes with the ionic liquid-supported Schiff base 1-{2-(2-hydroxy-5-chlorobenzylamine)ethyl}-3-methylimidazolium tetrafluoroborate (primary ligand) and 1-methyl imidazole (secondary ligand) and were synthesized and characterized by PXRD, SEM, ESI-MS, UV-Visible, FT-IR, 1H NMR, 13CNMR spectroscopic and various analytical (elemental analysis and magnetic susceptibility measurements) methods. Based on these spectra and spectral data hexa coordinated geometries were assigned for the synthesized mixed ligand metal (II) complexes. Antimicrobial activity of the mixed ligand Mn(II), Ni(II), Cu(II) complexes with respect to the Schiff base against two gram positive (Staphylococcus aureus and Bacillus cereus) and two were gram negative (Escherichia coli and Klebsiella pneumoniae) were conducted to assess their antibacterial activities. The Schiff base along with the mixed ligand complexes exhibited very significant responses for gram positive and negative bacterial samples though maximum inhibition zone was produced by Ni(II) complex while the minimum inhibition zone was produced by Cu(II) complex in plates of Staphylococcus aureus.

Graphical Abstract

Acknowledgements

The authors are grateful to the SAIF, NEHU, Guwahati, India for 13CNMR, 1H NMR and SAIF, CDRI, Lucknow, India for ESI-MS and elemental analysis. We indebted to USIC, University of North Bengal, Darjeeling, India and Sikkim University, Sikkim, India for SEM and PXRD spectra, respectively.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.